DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $84,266,000 | +7.0% | 589,830 | -1.2% | 1.14% | +8.5% |
Q1 2019 | $78,752,000 | +29.6% | 597,000 | +1.3% | 1.05% | +8.1% |
Q4 2018 | $60,782,000 | -6.9% | 589,425 | -1.9% | 0.97% | +10.0% |
Q3 2018 | $65,260,000 | +15.9% | 600,587 | +5.3% | 0.88% | +9.7% |
Q2 2018 | $56,297,000 | -3.8% | 570,501 | -4.5% | 0.80% | -2.8% |
Q1 2018 | $58,498,000 | +3.7% | 597,462 | -1.7% | 0.82% | +3.3% |
Q4 2017 | $56,395,000 | +9.3% | 607,578 | +1.0% | 0.80% | -11.0% |
Q3 2017 | $51,604,000 | -0.2% | 601,583 | -1.8% | 0.90% | -5.4% |
Q2 2017 | $51,711,000 | -58.4% | 612,766 | -57.9% | 0.95% | +2.0% |
Q1 2017 | $124,363,000 | +6.9% | 1,454,028 | -2.7% | 0.93% | +2.0% |
Q4 2016 | $116,313,000 | -3.1% | 1,494,259 | -2.5% | 0.91% | +0.7% |
Q3 2016 | $120,088,000 | -24.3% | 1,531,926 | -2.5% | 0.91% | -25.7% |
Q2 2016 | $158,708,000 | +2.3% | 1,571,368 | -3.9% | 1.22% | +2.2% |
Q1 2016 | $155,067,000 | +0.2% | 1,634,694 | -1.9% | 1.19% | -0.7% |
Q4 2015 | $154,801,000 | +1.5% | 1,666,682 | -6.9% | 1.20% | -2.6% |
Q3 2015 | $152,463,000 | -1.7% | 1,789,265 | -1.2% | 1.24% | +10.5% |
Q2 2015 | $155,032,000 | -0.1% | 1,811,328 | -0.9% | 1.12% | -3.0% |
Q1 2015 | $155,242,000 | -21.3% | 1,828,533 | -20.5% | 1.15% | -15.7% |
Q4 2014 | $197,208,000 | +10.3% | 2,300,874 | -2.2% | 1.37% | +7.4% |
Q3 2014 | $178,717,000 | -8.9% | 2,352,155 | -5.6% | 1.27% | -4.6% |
Q2 2014 | $196,091,000 | -3.9% | 2,490,680 | -8.4% | 1.34% | -3.3% |
Q1 2014 | $204,034,000 | -8.8% | 2,720,459 | -6.1% | 1.38% | -6.4% |
Q4 2013 | $223,618,000 | +5.1% | 2,896,600 | -5.6% | 1.47% | +0.3% |
Q3 2013 | $212,673,000 | +8.9% | 3,067,993 | -0.6% | 1.47% | +8.2% |
Q2 2013 | $195,334,000 | – | 3,085,847 | – | 1.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |